252 related articles for article (PubMed ID: 28322617)
1. Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.
Nickel B; Brito JP; Barratt A; Jordan S; Moynihan R; McCaffery K
Thyroid; 2017 May; 27(5):661-671. PubMed ID: 28322617
[TBL] [Abstract][Full Text] [Related]
2. Patients' experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study.
Nickel B; Brito JP; Moynihan R; Barratt A; Jordan S; McCaffery K
BMC Cancer; 2018 Mar; 18(1):242. PubMed ID: 29499654
[TBL] [Abstract][Full Text] [Related]
3. A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.
Brito JP; Ito Y; Miyauchi A; Tuttle RM
Thyroid; 2016 Jan; 26(1):144-9. PubMed ID: 26414743
[TBL] [Abstract][Full Text] [Related]
4. From Overdiagnosis to Overtreatment of Low-Risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients.
Jensen CB; Saucke MC; Francis DO; Voils CI; Pitt SC
Thyroid; 2020 May; 30(5):696-703. PubMed ID: 31910092
[No Abstract] [Full Text] [Related]
5. Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy.
Ardito G; Revelli L; Giustozzi E; Salvatori M; Fadda G; Ardito F; Avenia N; Ferretti A; Rampin L; Chondrogiannis S; Colletti PM; Rubello D
Clin Nucl Med; 2013 Jan; 38(1):25-8. PubMed ID: 23242040
[TBL] [Abstract][Full Text] [Related]
6. Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment.
Nickel B; Howard K; Brito JP; Barratt A; Moynihan R; McCaffery K
JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):887-896. PubMed ID: 30140909
[TBL] [Abstract][Full Text] [Related]
7. Terminology Change for Small Low-Risk Papillary Thyroid Cancer As a Response to Overtreatment: Results from Three Australian Community Juries.
Shih P; Nickel B; Degeling C; Thomas R; Brito JP; McLeod DSA; McCaffery K; Carter SM
Thyroid; 2021 Jul; 31(7):1067-1075. PubMed ID: 33238815
[No Abstract] [Full Text] [Related]
8. Active Surveillance as First-Line Management of Papillary Microcarcinoma.
Ito Y; Miyauchi A
Annu Rev Med; 2019 Jan; 70():369-379. PubMed ID: 30230964
[TBL] [Abstract][Full Text] [Related]
9. Effect of a Change in Papillary Thyroid Cancer Terminology on Anxiety Levels and Treatment Preferences: A Randomized Crossover Trial.
Nickel B; Barratt A; McGeechan K; Brito JP; Moynihan R; Howard K; McCaffery K
JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):867-874. PubMed ID: 30335875
[TBL] [Abstract][Full Text] [Related]
10. Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital.
Ito Y; Miyauchi A; Kudo T; Ota H; Yoshioka K; Oda H; Sasai H; Nakayama A; Yabuta T; Masuoka H; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Thyroid; 2016 Jan; 26(1):156-60. PubMed ID: 26670937
[TBL] [Abstract][Full Text] [Related]
11. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
12. Papillary thyroid microcarcinoma: optimal management versus overtreatment.
Walgama E; Sacks WL; Ho AS
Curr Opin Oncol; 2020 Jan; 32(1):1-6. PubMed ID: 31633497
[TBL] [Abstract][Full Text] [Related]
13. Controversies in papillary microcarcinoma of the thyroid.
Piersanti M; Ezzat S; Asa SL
Endocr Pathol; 2003; 14(3):183-91. PubMed ID: 14586064
[TBL] [Abstract][Full Text] [Related]
14. Public perceptions of changing the terminology for low-risk thyroid cancer: a qualitative focus group study.
Nickel B; Semsarian C; Moynihan R; Barratt A; Jordan S; McLeod D; Brito JP; McCaffery K
BMJ Open; 2019 Feb; 9(2):e025820. PubMed ID: 30813118
[TBL] [Abstract][Full Text] [Related]
15. Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.
Ito Y; Miyauchi A; Oda H
Eur J Surg Oncol; 2018 Mar; 44(3):307-315. PubMed ID: 28343733
[TBL] [Abstract][Full Text] [Related]
16. Management of Papillary Thyroid Microcarcinoma.
Brito JP; Hay ID
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):199-213. PubMed ID: 30717902
[TBL] [Abstract][Full Text] [Related]
17. Conservative Surveillance Management of Low-Risk Papillary Thyroid Microcarcinoma.
Miyauchi A; Ito Y
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):215-226. PubMed ID: 30717903
[TBL] [Abstract][Full Text] [Related]
18. Low-risk papillary thyroid microcarcinoma: Optimal management toward a more conservative approach.
Ramundo V; Sponziello M; Falcone R; Verrienti A; Filetti S; Durante C; Grani G
J Surg Oncol; 2020 May; 121(6):958-963. PubMed ID: 32189352
[TBL] [Abstract][Full Text] [Related]
19. Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review].
Ito Y; Oda H; Miyauchi A
Endocr J; 2016 Apr; 63(4):323-8. PubMed ID: 26632168
[TBL] [Abstract][Full Text] [Related]
20. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
Sasaki T; Miyauchi A; Ito Y; Kudo T; Kanemura N; Sano T; Kawano S; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Miya A
Thyroid; 2021 Feb; 31(2):217-223. PubMed ID: 32664805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
